PKNOX1 and metabolic dysfunction-associated steatotic liver disease: We then aimed to identify the role of miR‐17 family‐mediated regulation of Pknox1 in hepatic lipogenesis and IR, in order to seek new intervention targets for the prevention and treatment of progressive liver disease caused by T2DM and NAFLD complication.